Cheryl A. Madsen
Conseiller Juridique Général chez VIRACTA THERAPEUTICS, INC.
Profil
Cheryl A.
Madsen is currently the Senior Vice President-Regulatory Affairs at Viracta Therapeutics, Inc. She previously worked as the Senior Director at Medivation, Inc., Vice President-Regulatory Affairs at Peloton Therapeutics, Inc., and Vice President-Regulatory Affairs at Calithera Biosciences, Inc. She obtained her undergraduate degree from the University of California, Santa Cruz.
Postes actifs de Cheryl A. Madsen
| Sociétés | Poste | Début |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Cheryl A. Madsen
| Sociétés | Poste | Fin |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | Conseiller Juridique Général | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - |
| CALITHERA BIOSCIENCES, INC. | Conseiller Juridique Général | - |
Formation de Cheryl A. Madsen
| University of California, Santa Cruz | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
